baber/WOPTO huggingface dataset:
Patent NZ-595841-A (NZ)
Title: A method for low-latency streaming of video to a user of a video game or application
Inventor: FURMAN SCOTT
IPC: A63F13/12
Filed: 2010-03-17
Abstract: 595841 Disclosed is a computer-implemented method for streaming video. The method includes receiving, at a server, a request from a client remote from the server for executing a video game or application over one or more network interfaces. The method also includes transmitting control signals from the client to the server as the client plays the video game or uses the application. The control signals are transmitted over a network which includes public network components. The method also includes executing the video game or application on a server in response to the control signals. The execution of the video game or application produces an interactive compressed video stream comprising a plurality of compressed video images delivered over one or more networks to the client with a latency such that the user has the perception that the selected video game or application is responding instantly to the control signals. The method further includes receiving a signal from the client to determine that one or more compressed video images have not been successfully received and decoded by the client. In response to receipt of the signal, a new video frame is encoded to be dependent on a video frame known to have been successfully received by the client.
Patent NZ-597829-A (NZ)
Title: Multilayer films comprising starch
Inventor: CHEN CHANGPING
IPC: B32B27/06
Filed: 2010-07-20
Abstract: 597829 Disclosed herein is a multilayer film comprising at least a tri-Iayer structure, said tri-Iayer structure being made up of a core polymer layer interposed between two covering polymer layers that each comprise polyethylene, wherein the core polymer layer comprises a melt blend of polyethylene, thermoplastic starch, and ethylene acrylic acid copolymer. Preferably, wherein the core polymer layer comprises polyethylene in an amount ranging from about 5 wt% to about 85 wt%, ethylene acrylic acid copolymer in an amount ranging from about 2 wt% to about 25 wt%, and TPS in an amount ranging from about 10 wt% to about 80 wt% and the ethylene vinyl acetate copolymer is present in an amount ranging from about 0.2 wt% to about 2 wt%, relative to the other components present in the layer. Additionally, wherein the core polymer layer further comprises polyolefin wax. present in an amount ranging from about 0.2 wt% to about 2 wt%, relative to the other components present in the core polymer layer. Additionally disclosed is a process for producing a multilayer film comprising at least a tri-Iayer structure, the process comprising forming the tri-Iayer structure by co-extruding a core polymer layer interposed between two covering polymer layers that each comprise polyethylene, wherein the core polymer layer comprises a melt blend of polyethylene, thermoplastic starch, and ethylene acrylic acid copolymer.
Patent NZ-598426-A (NZ)
Title: Use of antisecretory factors for treating intraocular hypertension
Inventor: HANSSON HANS-ARNE
IPC: A61K38/17
Filed: 2007-04-27
Abstract: Disclosed is a peptide having at least 80% identity with SEQ ID NO: 4 and/or a pharmaceutically acceptable salt thereof.
Patent NZ-603024-A (NZ)
Title: Three-dimensional weave-forming method for composites
Inventor: LIU FENG
IPC: D04C1/00
Filed: 2010-08-16
Abstract: 603024 A three-dimensional weave-moulding method for composite material. The method includes: a) dividing the CAD model into layers according to the structural performance and the overall dimension features of a component, and optimizing grid filling paths for each single layer; b) disposing weaving guiding poles (3) on a controllable digital layout template according to the feature requirement of the component and based on pre-set rules and intervals; c) passing guiding sleeves (1, 2) through the hollow guiding poles (3) and turning the guiding sleeves (1, 2) inside-out, and then fixing the guiding sleeves (1, 2) on the controllable digital template; d) selecting, in conjunction with the performance requirement of the component, filaments of the corresponding material as raw material for weaving processing, winding the filaments around the weaving guiding poles (3) to weave the patterns in this layer, and locking the guiding sleeves (1, 2); e) descending the controllable digital layout template by one layer after the weaving of one layer is finished, driving the guiding sleeves (1, 2) to be exposed a pre-set distance, to form a new layer of layout template in preparation for the weaving of the next layer; f) weaving layer by layer according to Step e until the whole component is finished; g) dismounting the component from the controllable digital layout template, and sewing the whole component along the guiding sleeves (1, 2); and h) dipping the component in resin to finish the manufacture of the composite part.
Patent NZ-612852-A (NZ)
Title: Low-tack, hydrophobic ophthalmic device materials
Inventor: LAREDO WALTER R
IPC: G02B1/04
Filed: 2012-02-07
Abstract: Disclosed herein is a low-tack, hydrophobic, high refractive index, copolymeric ophthalmic device material formed by polymerizing a mixture comprising: (a) 70% (w/w) or more of an aryl acrylic hydrophobic monomer of the formula (A); (b) 0.3 – 10 % (w/w) of an acryloxy-terminated poly(ethylene glycol) –polydimethylsiloxane-poly(ethylene glycol) ABA block copolymer of formula (1); (c) 5 – 30 % (w/w) of a siloxane monomer of formula (2); (d) 2 – 20% (w/w) of a hydrophilic monomer selected from the group consisting of: hydroxy(C2–C4alkyl)methacrylates, glycerol methacrylate, and N-vinyl pyrrolidone; (e) a cross-linking monomer, preferably 1,4-butanediol dimethacrylate or triethylene glycol dimethacrylate; and (f) a reactive UV absorber, preferably 2-(2ʹ-hydroxy-3ʹ-methallyl-5ʹ-methylphenyl)benzotriazole or 3-(2H-benzo[d][1,2,3]triazolyl-2-yl-4-hydroxyphenylethyl methacrylate. Said copolymeric ophthalmic device material is especially useful as intraocular lens material, and contains one or more aryl acrylic hydrophobic monomers as principal device-forming monomers, a tack-reducing block copolymer additive and a glistening-reducing additive. In addition to its use as intraocular lens materials, the present material is also suitable for use in other implantable ophthalmic devices.
Patent NZ-617741-A (NZ)
Title: Marine survival pod
Inventor: SHACKCLOTH GLEN
IPC: B63C9/08
Filed: 2012-04-18
Abstract: Disclosed is a water floatation survival pod (1) with multiple storage containers of survival tools that are accessible by the pod user regardless of the pod’s orientation . The floatation survival pod comprises an elongate floatation body having sufficient buoyancy to remain afloat when holding a plurality of persons, handles (4) formed on the sides (5) thereof for grasping by said persons, one or more ports (6) formed in the top and bottom of said body for receiving and mounting a flare or the like and two or more compartments (7) formed either side of the longitudinal axis of said body for storing survival tools wherein said compartments provide access to said survival tools when said pod is floating in any orientation without compromising the floatation of said pod or comprising the security of persons using said pod.
Patent NZ-625511-A (NZ)
Title: Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-b]pyrazin-2(1h)-one, a solid form thereof and methods of their use
Inventor: XU JEAN
IPC: C07D487/04
Filed: 2012-11-30
Abstract: Disclosed herein are compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one, solid forms, isotopologues and metabolites thereof, stearic acid and lactose monohydrate and methods of their use for the treatment of a disease disorder, or condition such as cancer, especially solid tumours, non-Hodgkin lymphoma and glioblastoma multiforme, an inflammatory condition, an immunological condition, a neurodegenerative disease, diabetes, obesity, a neurological disorder, an age-related disease, or a cardiovascular condition.
Patent NZ-627103-A (NZ)
Title: Specific binding proteins and uses thereof
Inventor: RITTER GERD
IPC: G01N33/574
Filed: 2010-02-17
Abstract: Discloses use of an isolated anti-Epidermal Growth Factor Receptor (EGFR) IgG1 antibody conjugated to a cytotoxic agent, in the preparation of a medicament for treating cancer in a subject, wherein said antibody comprises a heavy chain variable region comprising the amino acid sequence set forth in SEQ ID NO: 164, and comprises a light chain variable region comprising the amino acid sequence set forth in SEQ ID NO: 166, and wherein said antibody further comprises a kappa light chain constant region, wherein the sequences are as defined in the complete specification.
Patent NZ-630141-A (NZ)
Title: Maternal supplement to enhance immune system of an infant
Inventor: GARSSEN JOHAN
IPC: A23L33/00
Filed: 2012-02-10
Abstract: Discloses a composition comprising a non-digestible oligosaccharide for use in enhancing an immune system and/or preventing an immune system related disorder in a mammalian subject, wherein the composition is for administration to a lactating, postpartum female who is breast-feeding the mammalian subject.
Patent NZ-717780-A (NZ)
Title: Systems and methods of communicating redundant frame information
Inventor: RAJENDRAN VIVEK
IPC: H04L1/08
Filed: 2014-10-09
Abstract: A method includes receiving a second audio frame at a decoder. The second audio frame follows a first audio frame in an audio signal and includes a first number of bits allocated to primary coding information associated with the second audio frame, a second number of bits allocated to redundant coding information associated with the first audio frame, and an indicator of a frame type of the first audio frame. In response to a frame erasure condition associated with the first audio frame, the second number of bits is determined based on the indicator and used to decode the first audio frame. In clean channel conditions, the first audio frame is received and decoded based on primary coding bits in the first audio frame, and the first number of bits is determined based on the indicator and used to decode the second audio frame.
Patent NZ-719220-A (NZ)
Title: Reduction of substances in contaminated fluids using a naturally occurring biological growth media
Inventor: CALHOUN JASON
IPC: C02F11/14
Filed: 2014-10-21
Abstract: A treatment process for municipal, commercial, industrial, and institutional fluids containing one or more substances at a first concentration includes a contactor, an aerator, and a separator. The fluid is mixed with a powdered natural lignocellulosic material (”PNLM”), a microbial growth inoculum, and at least a portion of the fluid in the contactor to provide a mixture that includes an established, acclimated microbial growth in the fluid. The mixture is introduced to an aerator where physical binding and chemical bonding of at least some of the one or more substances to the PNLM additionally physiological uptake by microbial growth in a biosludge reduces the concentration of at least some of the one or more substances in the fluid discharged from the aerator to a second concentration. A portion of the biosludge is recycled from the aerator to the contactor to provide the inoculum of biosludge containing established, acclimated, microbial organisms on the PNLM biological growth media. The biosludge is then separated to recover at least a portion of the PNLM that is recycled to the contactor.
Patent NZ-719318-A (NZ)
Title: Compositions and methods for coating dry pet food kibbles
Inventor: DECKARD MAQUEL
IPC: A23K50/40
Filed: 2014-11-12
Abstract: Compositions and methods are provided for evenly coating or glazing dry pet food kibbles for improved palatability without loss of crunchiness of the dry kibbles over an extended time period. The coating compositions comprise water and at least one of a gum or a modified starch. The coating composition can comprise an additional ingredient such as one or more of a flavor, a color, an emulsified or particulate meat, an emulsified or particulate fruit or vegetable, an antioxidant, a vitamin, a mineral, a non-replicating microorganism, a fiber or a prebiotic. In an embodiment, the coating composition can include dextrose and/or glycine. After mixing and retorting, the coating composition can be a viscous paste with a viscosity of 2500 to 4000 centipoises, preferably 3000 to 3500 centipoises, as measured at room temperature.
Patent NZ-732352-A (NZ)
Title: Updating language understanding classifier models for a digital personal assistant based on crowd-sourcing
Inventor: KANNAN VISHWAC SENA
IPC: G10L15/22
Filed: 2016-01-15
Abstract: A method for updating language understanding classifier models includes receiving via one or more microphones of a computing device, a digital voice input from a user of the computing device. Natural language processing using the digital voice input is used to determine a user voice request. Upon determining the user voice request does not match at least one of a plurality of pre-defined voice commands in a schema definition of a digital personal assistant, a GUI of an end-user labeling tool is used to receive a user selection of at least one of the following: at least one intent of a plurality of available intents and/or at least one slot for the at least one intent. A labeled data set is generated by pairing the user voice request and the user selection, and is used to update a language understanding classifier.
Patent NZ-735805-A (NZ)
Title: Industrial and hydrocarbon gas liquefaction
Inventor: NIKIFORUK COLIN F
IPC: F25J1/02
Filed: 2016-03-23
Abstract: A method for liquefaction of industrial gases or gas mixtures (hydrocarbon and/or non-hydrocarbon) uses a modified aqua-ammonia absorption refrigeration system (ARP) that is used to chill the gas or gas mixture during the liquefaction process. The gas may be compressed to above its critical point, and the heat of compression energy may be recovered to provide some or all of the thermal energy required to drive the ARP. The method utilizes a Joule Thomson (JT) adiabatic expansion process which results in no requirement for specialty cryogenic rotating equipment. The aqua-ammonia absorption refrigeration system includes a vapour absorber tower (VAT) which permits the recovery of some or all of the heat of solution and heat of condensation energy in the system when anhydrous ammonia vapour is absorbed into a subcooled lean aqua-ammonia solution. The modified ARP with VAT may achieve operating pressures as low as 10 kPa which results in ammonia gas chiller operating temperatures as low as -71 C.
Patent NZ-735824-A (NZ)
Title: System for managing packages of shuffled playing cards
Inventor: SHIGETA YASUSHI
IPC: G08B25/00
Filed: 2014-10-20
Abstract: The present invention directed to a system has been made for securely managing packages of shuffled playing cards. The managing system comprising: packages (2) of shuffled playing cards; a game table (11); a storage box; and a control device (7). The control device (7) monitors whether or not the packages (2) are present in the storage box by repeatedly collating ID codes of the packages (2) read by readers with registered ID codes of the packages in a database (7b), and for outputting monitoring results.
Patent NZ-744629-A (NZ)
Title: Methods for inhibiting fibrosis in a subject in need thereof
Inventor: DUDLER THOMAS
IPC: C07K16/40
Filed: 2017-01-05
Abstract: In one aspect, the invention provides methods for treating, inhibiting, alleviating or preventing fibrosis in a mammalian subject suffering, or at risk of developing a disease or disorder caused or exacerbated by fibrosis and/or inflammation. In one embodiment, the invention provides methods of treating a subject suffering from renal fibrosis. In one embodiment, the invention provides methods of reducing proteinuria in a subject suffering from a renal disease or condition associated with proteinuria. The methods comprise the step of administering, to a subject in need thereof, an amount of a MASP-2 inhibitory agent effective to inhibit MASP-2-dependent complement activation. In a particular embodiment, the MASP-2 inhibitory agent is for treating a subject suffering from steroid-dependent Immunoglobulin A Nephropathy (IgAN), wherein the MASP-2 inhibitory agent is present in an amount effective to improve renal function and decrease or eliminate corticosteroid dosage in said subject.
Patent NZ-759601-A (NZ)
Title: Aggrecan binding immunoglobulins
Inventor: BESTE GERALD
IPC: C07K16/18
Filed: 2018-06-04
Abstract: The present invention relates to immunoglobulin single variable domain (ISV) that specifically binds to human Aggrecan and more in particular to polypeptides, nucleic acids encoding such polypeptides; to methods for preparing such polypeptides; to compositions and in particular to pharmaceutical compositions that comprise such polypeptides, for prophylactic, therapeutic or diagnostic purposes. In particular, the ISV’s of the present invention inhibit the activity of Aggrecan.
Patent NZ-766062-A (NZ)
Title: Automated password generation and change
Inventor: BELOTE THOMAS
IPC: H04L9/08
Filed: 2015-07-29
Abstract: An identity management system detects the occurrence of a trigger event, such as a time period expiration, or an action on the identity management system. The identity management system accordingly generates a new password for an account of a user on a third-party service and causes the account of the user on the third-party service to use the new password. The identity management system can also detect a manual user change of a password for a third-party service and cause configuration of client devices of the user to reflect the new password.
Patent NZ-772135-A (NZ)
Title: Systems and methods for facilitating clinical messaging in a network environment
Inventor: DEOSTHALE CHAITANYA
IPC: G06F3/12
Filed: 2019-07-12
Abstract: Various techniques for facilitating communication with and across a clinical environment and a cloud environment are described. These techniques may include converting pump messages into standardized dataset messages, merging the messages into a cache, transmitting the messages to a cloud server, detecting network outages, clearing an outbound queue, detecting missing messages, authenticating a connectivity adapter for cloud access, providing a segmented data structure, among others.
Patent PT-103949-A (PT)
Title: Estruturas inteligentes para próteses ósseas
Inventor: FRIAS CLARA MARIA MESQUITA
IPC: A61F2/28
Filed: 2008-01-30
Abstract: A PRESENTE INVENÇÃO DIZ RESPEITO A ESTRUTURAS QUE PODEM SER USADAS EM PRÓTESES ÓSSEAS, E BASEIA-SE NUM CONCEITO DE MULTI-CAMADAS COM REDES DE BIOSSENSORES E BIOACTUADORES, MONITORIZANDO CONTÍNUA E ACTIVAMENTE O DESEMPENHO E INTEGRIDADE DE IMPLANTES ÓSSEOS DENTRO DE ORGANISMOS VIVOS. A REDE DE BIOSSENSORES INTEGRA DIFERENTES TECNOLOGIAS DE SENSORES (ÓPTICOS, PIEZORESISTIVOS, PIEZOELÉCTRICOS E PIROELÉCTRICOS) QUE PERMITEM A MONITORIZAÇO DO IMPLANTE ÓSSEO EM TEMPO REAL, DURANTE E APÓS A CIRURGIA, SENDO A REDE DE ACTUADORES COMPOSTA POR MATERIAIS BIOMIMÉTICOS QUE ESTIMULAM O CRESCIMENTO DO TECIDO ÓSSEO ATRAVÉS DE EFEITOS BIOLÓGICOS, MECÂNICOS, ELECTROMECÂNICOS, TÉRMICOS E/OU ELECTROQUÍMICOS. ESTA INVENÇÃO ENQUADRA-SE NO CONCEITO EMERGENTE DOS MATERIAIS E ESTRUTURAS INTELIGENTES DIRECCIONADOS PARA APLICAÇÕES MÉDICAS, COMO POR EXEMPLO PARA IMPLANTES DE ANCA, JOELHO, OMBRO E ORTODONTICOS, ATRIBUINDO FUNÇÕES SECUNDÁRIAS S PRÓTESES ÓSSEAS, TAIS COMO MEDIDAS CLÍNICAS PREVENTIVAS, MEDIANTE RESULTADOS DA MONITORIZAÇÃO, ACTUALIZAÇÃO AUTOMÁTICA DAS BASES DE DADOS DE IMPLANTES, CAPACIDADE DE AUTO- REPARAÇÃO, MINIMIZAÇÃO DO INSUCESSO DOS IMPLANTES, LIBERTAÇÃO CONTROLADA DE FÁRMACOS, E UM MÉTODO DE IDENTIFICAÇÃO DO HISTORIAL CLÍNICO DO DOENTE EM CASO DE ACIDENTE OU CATÁSTROFE.
Patent PT-104103-A (PT)
Inventor: SOUSA JOSE CARLOS CALDEIRA PIN
IPC: B65G15/10
Filed: 2008-06-16
Abstract: The present invention refers to an automated system for handling and distribution of products in its manufacturing process and to a multi-ring modular system with an overtaking system allowing to supply in a flexible and automated manner the workstations, allowing the simultaneous products manufacturing with several operative ranges without having throttling or productivity losses.  The system is based in a modular frame ( fig. 1 ), comprising curve modules (1), workstation modules (2), straight modules (3 and 8), transfer modules (4), association station modules (5), pallets (6), interconnection between sections modules (7), and a set of complementary components, all incorporated in an articulated form between them. All the system is further controlled and managed by computer software and a programmable automated robot that assures the automated movement and distribution of the products running in the several workstations.
Patent PT-104445-A (PT)
Title: Método, sistema de processamento de dados e programa de computador de interacção por reconhecimento de voz
Inventor: RILHAS ROGERIO DAVID PEDROSO
IPC: G10L15/07
Filed: 2009-03-19
Abstract: A PRESENTE INVENÇÃO ESTÁ RELACIONADA COM TECNOLOGIAS DE RECONHECIMENTO DE FALA, SÍNTESE DE FALA, E INTRODUÇÃO DE INFORMAÇÃO VIA VOZ OU MULTIFREQUÊNCIA. A PRESENTE INVENÇÃO É ÚTIL PARA OBTER ROBUSTEZ A AMBIENTES COM NÍVEL ELEVADO DE RUÍDO OU ORADORES POUCO EXPERIENTES, APROVEITANDO TAMBÉM O HISTÓRICO DE UTILIZAÇÃO PARA PREVER E DIRECCIONAR INTERACÇÕES. O COMPORTAMENTO DO SISTEMA É AUTOMATICAMENTE ADAPTÁVEL, ATRAVÉS DA SOLUÇÃO DE RECONHECIMENTO DE FALA POR VÁRIOS MOTORES EM AGRUPAMENTO, CLUSTER, (UTILIZANDO TECNOLOGIA IN DOIT OU OUTRA EQUIVALENTE), OU UTILIZANDO A INTRODUÇÃO DE DADOS POR MULTIFREQUÊNCIA. UTILIZAM-SE: A QUALIDADE DA INTERACÇÃO, MEDIDA ATRAVÉS DO NÍVEL DE RUÍDO AMBIENTE; OS NÍVEIS DE CONFIANÇA RELATIVOS AO PROCESSO DE RECONHECIMENTO; O HISTÓRICO DE UTILIZAÇÃO DO SISTEMA PARA CADA UTILIZADOR; E TAMBÉM O NÍVEL DE CONFIANÇA RELATIVO À EFICIÊNCIA DE INTERACÇÃO (BASEADA NO NÚMERO DE ERROS POR INTERACÇÃO, NÚMERO DE REPETIÇÕES PEDIDO PELO SISTEMA E DE EXECUÇÕES COM SUCESSO POR INTERACÇÃO).
Patent PT-105822-A (PT)
Title: Estrutura de controlo de funcionamento para um dispositivo de teste de continuidade
Inventor: KOGASUMI KOZO
IPC: F16K1/00
Filed: 2011-07-20
Abstract: PROPORCIONA-SE UMA ESTRUTURA DE CONTROLO DE FUNCIONAMENTO PARA UM DISPOSITIVO DE TESTE DE CONTINUIDADE PARA EXECUTAR O BLOQUEIO UM CONECTOR E A ACTUAÇÃO DE UMA PEÇA DE TESTE DE CONTINUIDADE, NO MOMENTO OPORTUNO, A CUSTO REDUZIDO, FACILMENTE E COM SEGURANÇA, INCLUINDO UMA PEÇA 3 DE FIXAÇÃO DE CONECTOR, UMA PEÇA 4 DE TESTE DE CONTINUIDADE TENDO UM PINO 12 DE PROVA, UM PRIMEIRO CILINDRO 16 PARA BLOQUEAR UM CONECTOR 10 NA PEÇA DE FIXAÇÃO DE CONECTOR, UM SEGUNDO CILINDRO 15 PARA MOVER A PEÇA DE TESTE DE CONTINUIDADE PARA A PEÇA DE FIXAÇÃO DE CONECTOR, EM QUE OS BUJÕES 30 E 54 DO PRIMEIRO CILINDRO E DO SEGUNDO CILINDRO, RESPECTIVAMENTE, SÃO ABASTECIDOS COM O MESMO AR COMPRIMIDO, UMA VÁLVULA 26 DE CONTROLO DE VELOCIDADE SENDO PROPORCIONADA DENTRO DE UM BUJÃO 30 DO SEGUNDO CILINDRO 15, UM ORIFÍCIO 28 FINO, MAIS FINO DO QUE UM ORIFÍCIO 56 NUM BUJÃO 54 DO PRIMEIRO CILINDRO, SENDO PROPORCIONADO NA VÁLVULA DE CONTROLO DE VELOCIDADE E EM QUE A PEÇA DE TESTE DE CONTINUIDADE É ACTUADA PELO SEGUNDO CILINDRO ATRAVÉS DO ORIFÍCIO FINO APÓS O BLOQUEIO DO CONECTOR PELO PRIMEIRO CILINDRO. UM ORIFÍCIO 37 PARA DESCARGA DE AR É PROPORCIONADO NA VÁLVULA 26 DE CONTROLO DE VELOCIDADE E ESTÁ LIGADO A UM ORIFÍCIO 31 DO BUJÃO ATRAVÉS DE UMA ABERTURA 38 ENTRE A CIRCUNFERÊNCIA EXTERIOR DA VÁLVULA DE CONTROLO DE VELOCIDADE E A CIRCUNFERÊNCIA INTERIOR DO BUJÃO 30 DO SEGUNDO CILINDRO 15 E EM QUE UMA VÁLVULA 36 DE TESTE É PROPORCIONADA NA ABERTURA.